Suscripción a Biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicado 4 números por año

ISSN Imprimir: 0893-9675

ISSN En Línea: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Antiangiogenic Therapies Targeting the Vascular Endothelia Growth Factor Signaling System

Volumen 17, Edición 1, 2012, pp. 51-67
DOI: 10.1615/CritRevOncog.v17.i1.50
Get accessGet access

SINOPSIS

Angiogenesis is critical to the growth of human tumors and the development of metastasis. Amongst the many proangiogenic mechanisms identified, the vascular endothelial growth factor (VEGF) signaling pathway has been implicated as the key regulator of tumor neovascularisation. Various therapeutic agents targeting the VEGF pathway have been successfully developed, with many now approved and in routine clinical use. In general, VEGF-mediated angiogenesis can be inhibited by 2 approaches: antibodies directed against VEGF ligands or VEGF receptors (VEGFRs) and tyrosine kinase inhibitors targeting the VEGFRs. Thus far, clinical benefits achieved with VEGF-targeted agents are limited by their modest efficacy and the development of resistance. With no shortage of drugs in development, the lack of well-validated biomarkers to predict for response or resistance to VEGF-directed therapies is now becoming a key factor limiting the further rational development of this class of anticancer agent. This review discusses the biology of VEGF signaling, the clinical efficacy of VEGF-targeting therapies, potential mechanisms of resistance, and emerging predictive biomarkers.

CITADO POR
  1. Okamoto Isamu, Arao Tokuzo, Miyazaki Masaki, Satoh Taroh, Okamoto Kunio, Tsunoda Takuya, Nishio Kazuto, Nakagawa Kazuhiko, Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors, Cancer Science, 103, 12, 2012. Crossref

  2. Neal Joel W, Wakelee Heather A, Aflibercept in lung cancer, Expert Opinion on Biological Therapy, 13, 1, 2013. Crossref

  3. Qi Wei-Xiang, Lin Feng, Sun Yuan-jue, Tang Li-Na, He Ai-Na, Yao Yang, Shen Zan, Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis, Cancer Chemotherapy and Pharmacology, 71, 2, 2013. Crossref

  4. Langenkamp Elise, Kamps Jan A. A. M., Mrug Michal, Verpoorte Elisabeth, Niyaz Yilmaz, Horvatovich Peter, Bischoff Rainer, Struijker-Boudier Harry, Molema Grietje, Innovations in studying in vivo cell behavior and pharmacology in complex tissues – microvascular endothelial cells in the spotlight, Cell and Tissue Research, 354, 3, 2013. Crossref

  5. Zhao Daxian, Qin Chuanjie, Fan Xiaohui, Li Yuncong, Gu Binhe, Inhibitory effects of quercetin on angiogenesis in larval zebrafish and human umbilical vein endothelial cells, European Journal of Pharmacology, 723, 2014. Crossref

  6. Meehan Brian, Garnier Delphine, Dombrovsky Alexander, Lau Karrie, D’Asti Esterina, Magnus Nathalie, Rak Janusz, Ageing-related responses to antiangiogenic effects of sunitinib in atherosclerosis-prone mice, Mechanisms of Ageing and Development, 140, 2014. Crossref

  7. Voss Stephan D., Glade-Bender Julia, Spunt Sheri L., DuBois Steven G., Widemann Brigitte C., Park Julie R., Leary Sarah E. S., Nelson Marvin D., Adamson Peter C., Blaney Susan M., Weigel Brenda, Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: A report from the children's oncology group phase I consortium, Pediatric Blood & Cancer, 62, 1, 2015. Crossref

  8. Wang Huaijun, Kaneko Osamu F., Tian Lu, Hristov Dimitre, Willmann Jürgen K., Three-Dimensional Ultrasound Molecular Imaging of Angiogenesis in Colon Cancer Using a Clinical Matrix Array Ultrasound Transducer, Investigative Radiology, 50, 5, 2015. Crossref

  9. Ravez Séverine, Castillo-Aguilera Omar, Depreux Patrick, Goossens Laurence, Quinazoline derivatives as anticancer drugs: a patent review (2011 – present), Expert Opinion on Therapeutic Patents, 25, 7, 2015. Crossref

  10. Baronzio Gianfranco, Parmar Gurdev, Baronzio Miriam, Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid, Frontiers in Oncology, 5, 2015. Crossref

  11. Spaide Richard F., Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization, American Journal of Ophthalmology, 160, 1, 2015. Crossref

  12. Zeng Yi, Zhang Le, Hu Zhiping, Cerebral insulin, insulin signaling pathway, and brain angiogenesis, Neurological Sciences, 37, 1, 2016. Crossref

  13. Sun Yunliang, Wu Congshan, Ma Jianxia, Yang Yu, Man Xiaohua, Wu Hongyu, Li Shude, Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling, Experimental Cell Research, 347, 2, 2016. Crossref

  14. Rusckowski Mary, Wang Yuzhen, Blankenberg Francis G., Levashova Zoia, Backer Marina V., Backer Joseph M., Targeted scVEGF/177Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy, EJNMMI Research, 6, 1, 2016. Crossref

  15. Huang Jianfei, Mei Haijun, Tang Zhiyuan, Li Jieying, Zhang Xiaojing, Lu Yixiang, Huang Fang, Jin Qin, Wang Zhiwei, Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation, Journal of Controlled Release, 245, 2017. Crossref

  16. Li Guo-Jian, Yang Yong, Yang Guo-Kai, Wan Jia, Cui Dao-Lei, Ma Zhen-Huan, Du Ling-Juan, Zhang Gui-Min, Slit2 suppresses endothelial cell proliferation and migration by inhibiting the VEGF-Notch signaling pathway, Molecular Medicine Reports, 15, 4, 2017. Crossref

  17. Zhou Ziwei, Yao Herui, Hu Hai, Disrupting Tumor Angiogenesis and “the Hunger Games” for Breast Cancer, in Translational Research in Breast Cancer, 1026, 2017. Crossref

  18. Arslan Burak, Onuk Özkan, Hazar İsmet, Aydın Muammer, Çilesiz Nusret Can, Eroglu Ali, Nuhoglu Barış, Prognostic Value of Endocan in Prostate Cancer: Clinicopathologic Association between Serum Endocan Levels and Biochemical Recurrence after Radical Prostatectomy, Tumori Journal, 103, 2, 2017. Crossref

  19. Song Wei, Zhao Xiaofei, Xu Jiarui, Zhang Han, Quercetin inhibits angiogenesis-mediated human retinoblastoma growth by targeting vascular endothelial growth factor receptor, Oncology Letters, 14, 3, 2017. Crossref

  20. SHI HUAIPING, LI WENYE, Inhibitory effects of human lactoferrin on U14 cervical carcinoma through upregulation of the immune response, Oncology Letters, 7, 3, 2014. Crossref

  21. Hyder Salman M., Mafuvadze Benford, Besch-Williford Cynthia, Novel Anti-angiogenic Therapies Using Naturally Occurring and Synthetic Drugs to Combat Progestin-Dependent Breast Cancer, in Cell and Molecular Biology of Breast Cancer, 2013. Crossref

  22. Gentile Pietro, Casella Donato, Palma Enza, Calabrese Claudio, Engineered Fat Graft Enhanced with Adipose-Derived Stromal Vascular Fraction Cells for Regenerative Medicine: Clinical, Histological and Instrumental Evaluation in Breast Reconstruction, Journal of Clinical Medicine, 8, 4, 2019. Crossref

  23. Zhou Xue, Yang Meng-Xue, Xu Jie, Yu Jie, Yang Bo, Sun Bo-Wen, Li Fei, Gong Qi-Hai, Yan Xiao-Yong, Yang Yi-Bin, Tian Mei, Study on the expression of CD14 + CD16 + monocytes and VEGF in peripheral blood of patients with type 2 diabetes mellitus and diabetic macroangiopathy, International Journal of Diabetes in Developing Countries, 40, 4, 2020. Crossref

  24. Shi Huan, Li Xin-Yu, Chen Yao, Zhang Xing, Wu Yong, Wang Zi-Xuan, Chen Pan-Hong, Dai Hui-Qi, Feng Ji, Chatterjee Sayantan, Li Zhong-Jie, Huang Xiao-Wei, Wei Hong-Qiao, Wang Jigang, Lu Guo-Dong, Zhou Jing, Quercetin Induces Apoptosis via Downregulation of Vascular Endothelial Growth Factor/Akt Signaling Pathway in Acute Myeloid Leukemia Cells, Frontiers in Pharmacology, 11, 2020. Crossref

  25. Gentile Pietro, Sterodimas Aris, Calabrese Claudio, De Angelis Barbara, Trivisonno Angelo, Pizzicannella Jacopo, Dionisi Laura, De Fazio Domenico, Garcovich Simone, Regenerative application of stromal vascular fraction cells enhanced fat graft maintenance: clinical assessment in face rejuvenation, Expert Opinion on Biological Therapy, 20, 12, 2020. Crossref

  26. Gentile Pietro, Kothari Ashutosh, Casella Donato, Calabrese Claudio, Fat Graft Enhanced With Adipose-Derived Stem Cells in Aesthetic Breast Augmentation: Clinical, Histological, and Instrumental Evaluation, Aesthetic Surgery Journal, 40, 9, 2020. Crossref

  27. Youngblood Victoria, Wang Shan, Song Wenqiang, Walter Debra, Hwang Yoonha, Chen Jin, Brantley-Sieders Dana M., Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient Endothelium, Molecular Cancer Research, 13, 3, 2015. Crossref

  28. Zou Mingyuan, Xu Peilan, Wang Li, Wang Lanlan, Li Tingting, Liu Cong, Shi Lei, Xie Jun, Li Wanyun, Wang Shengyu, Wu Guoqiu, Luo Fanghong, Wu Ting, Yan Jianghua, Design and construction of a magnetic targeting pro-coagulant protein for embolic therapy of solid tumors, Artificial Cells, Nanomedicine, and Biotechnology, 48, 1, 2020. Crossref

  29. Zhang Kexiong, Waxman David J., Impact of Tumor Vascularity on Responsiveness to Antiangiogenesis in a Prostate Cancer Stem Cell-Derived Tumor Model, Molecular Cancer Therapeutics, 12, 5, 2013. Crossref

  30. Kang W., Kim S., Lee S., Jeon E., Lee Y., Yun Y.R., Suh C.K., Kim H.W., Jang J.H., Characterization and optimization of vascular endothelial growth factor165 (rhVEGF165) expression in Escherichia coli, Protein Expression and Purification, 87, 2, 2013. Crossref

  31. Liu Xin-Yao, Wang Yu-Miao, Zhang Xiang-Yu, Jia Mei-Qi, Duan Hong-Quan, Qin Nan, Chen Ying, Yu Yang, Duan Xiao-Chuan, Alkaloid Derivative (Z)-3β-Ethylamino-Pregn-17(20)-en Inhibits Triple-Negative Breast Cancer Metastasis and Angiogenesis by Targeting HSP90α, Molecules, 27, 20, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain